CD274 and cancer: It was shown in different types of cancer (glioblastoma, HNSCC, melanoma, gastric, and lung cancer) that TEX-bound PD-L1 inhibited CD4+ and CD8+ T-cell activation and proliferation, resulting in anergic T-cells.